In a nutshell This study reviewed the use of continuous glucose monitoring (CGM) in pregnancy for women with type 1 diabetes (T1D). Some background Continuous glucose monitoring (CGM) automatically tracks blood glucose levels throughout the day and night. A CGM works through a tiny sensor inserted under the skin. The sensor tests...
Read More
In a nutshell This study assessed the potential benefits that using a continuous glucose monitoring device had for pregnant women with type 1 diabetes. The authors concluded that using the device improved maternal blood-sugar control and also reduced the likelihood of pregnancy and birth complications among mothers using the...
Read More
In a nutshell This study investigated the effect of continuous glucose monitoring (CGM) in managing blood sugar levels in patients with type 1 diabetes treated with multiple daily insulin injections. They found CGM resulted in a clinically meaningful improvement in glycemic (blood sugar) control. Some background Glycemic control is critical for...
Read More
In a nutshell The authors aimed to determine whether continuous glucose monitoring improved glycemia (glucose present in the blood) and prevented severe hypoglycemia events (dangerously low blood sugar levels) compared to self-monitoring of blood sugar levels in patients with impaired awareness of hypoglycemia. The authors concluded that continuous...
Read MoreIn a nutshell This study compared the accuracy of two continuous glucose monitoring systems for type 1 diabetes. Some background Patients with type 1 diabetes do not produce insulin (the hormone needed to break down glucose). Treatment involves replacing the insulin, either through injections or with an insulin pump (a machine that...
Read More
In a nutshell This study examined the experiences which type 1 diabetics and their caregivers have with continuous glucose (sugar) monitoring. Some background A continuous glucose monitor (CGM) is a device worn by patients with type 1 diabetes (T1D). It allows patients to view their blood glucose levels in real-time (every few minutes). This...
Read More
In a nutshell This study compared intermittent scanning continuous glucose monitoring (isCGM) with real-time continuous glucose monitoring (rtCGM) for the treatment of type 1 diabetes (T1D). It found that compared to isCGM, rt CGM resulted in increased time spent in range and improved blood glucose control in these patients. Some background...
Read More
In a nutshell This study compared the effectiveness of chiglitazar (Bilessglu) and sitagliptin (Januvia) on glycemic (blood glucose) variations, insulin resistance, and inflammation levels in patients with type 2 diabetes (T2D). The data showed that chiglitazar treatment was more effective at improving insulin resistance and inflammation compared...
Read More
In a nutshell This study evaluated the effect of physical activity interventions on glycemic variability (GV; glucose levels variations) in patients with diabetes. The data showed that physical activity was associated with significantly reduced GV in these patients. Some background Physical activity has been shown to reduce hemoglobin A1c (the...
Read More
In a nutshell This study looked at the use of closed-loop glucose control treatment for patients with type 2 diabetes (T2D) requiring dialysis. It found that compared to standard insulin therapy, closed-loop glucose control led to improved glucose control in these patients. Some background Closed-loop glucose control is a form of insulin...
Read More
In a nutshell This study compared two methods of continuous glucose monitoring (CGM) for patients with type 1 diabetes (T1D). It found that compared to intermittent monitoring, real-time monitoring led to better glucose control and reduced risk of severe hypoglycemia. Some background Treatment of type 1 diabetes (T1D) has improved in recent years...
Read More
In a nutshell This study looked at using a closed-loop system, which connects glucose tests automatically to an insulin pump, for children with type 1 diabetes (T1D). It found that a closed-loop system improved glucose control in these patients. Some background T1D is a condition in which the pancreas is unable to create the hormone insulin,...
Read More
